Eagle pharmaceutical stock
WebEagle Pharmaceuticals. EGRX. $30.30 ... as of April 12 4:00:00 PM EST. Eagle Pharmaceuticals (EGRX) Stock Price Performance. Eagle Pharmaceuticals (EGRX) … WebMar 13, 2024 · Eagle Pharmaceuticals (EGRX) came out with quarterly earnings of $1.10 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.85 per share a year ago ...
Eagle pharmaceutical stock
Did you know?
WebBusiness Wire. Aug-09-21 04:30PM. Eagle Pharmaceuticals, inc (EGRX) Q2 2024 Earnings Call Transcript. Motley Fool. Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. WebNov 14, 2024 · WOODCLIFF LAKE, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) announced today that the U.S. Food and Drug Administration (“FDA”) has accepted its investigational new drug (“IND”) application for CAL02, a novel first-in-class broad-spectrum anti-virulence agent …
WebReal time Eagle Pharmaceuticals (EGRX) stock price quote, stock graph, news & analysis. WebMar 2, 2024 · EAGLE PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEETS (In thousands, except share amounts) December 31, 2024. December 31, 2024. ASSETS: Current assets: Cash and cash equivalents $ 103,155 $ 109,775
WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … WebMar 24, 2024 · Eagle Pharmaceuticals, Inc. is a pharmaceutical company. The Company's products include Ryanodex, Bendeka, Belrapzo, Treakisym, Pemfexy, Barhemsys and Byfavo. Ryanodex is used for malignant hyperthermia. EP-4104 Ryanodex (dantrolene sodium) is used for the treatment of organophosphate exposure. Belrapzo, …
WebMar 24, 2024 · Eagle Pharmaceuticals to Host Third Quarter 2024 Financial Results on November 7, 2024. WOODCLIFF LAKE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- …
WebFind the latest Eagle Pharmaceuticals, Inc. (EGRX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance fishstick 1996WebDec 23, 2024 · As of December 22, 2024, Eagle Pharmaceuticals Inc had a $388.8 million market capitalization, putting it in the 52nd percentile of companies in the Pharmaceuticals industry. Currently, Eagle Pharmaceuticals Inc’s price-earnings ratio is 17.8. Eagle Pharmaceuticals Inc’s trailing 12-month revenue is $298.2 million with a 7.1% profit … can dogs eat potato chips safelyWebAug 5, 2024 · Fact checked. Eagle Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Eagle Pharmaceuticals shares (EGRX) are listed on the NASDAQ and all prices are listed in US Dollars. Eagle Pharmaceuticals employs 114 staff and has a trailing 12-month revenue of around $298.2 million. fishstick 3d modelWebApr 11, 2024 · Shares of EGRX opened at $30.99 on Tuesday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.27 and a current ratio of 1.70. Eagle … fishstick 1996 freeform introWeb19 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Eagle Pharmaceuticals (EGRX) can dogs eat pot roastWebMar 24, 2024 · Eagle Pharmaceuticals to Host Third Quarter 2024 Financial Results on November 7, 2024. WOODCLIFF LAKE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2024 third quarter finan... fishstick 1080x1080WebEagle Pharmaceuticals stocks (EGRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $44.11 – an increase of 4.27% over the previous week. Eagle Pharmaceuticals employs 114 staff and has a trailing 12-month revenue of around $298.2 million. can dogs eat prawns